News

Pharmabiz7h
WHO Foundation & Laerdal Global Health announce US$ 12.5 million to launch massive acute care scale up
WHO Foundation & Laerdal Global Health announce US$ 12.5 million to launch massive acute care scale up: Geneva Thursday, May ...
Pharmabiz29m
MediBuddy reports drop in anaemia rates in urban workforce at 12.14%, calls for screenings and preventive care
MediBuddy reports drop in anaemia rates in urban workforce at 12.14%, calls for screenings and preventive care: Our Bureau, Bengaluru Thursday, May 22, 2025, 17:15 Hrs [IST] MediB ...
Pharmabiz5m
IDMA urges govt to set up working group to ensure smooth implementation of QR code on top 300 brands
IDMA urges govt to set up working group to ensure smooth implementation of QR code on top 300 brands: Laxmi Yadav, Mumbai Wednesday, September 14, 2022, 08:00 Hrs [IST] In a bid t ...
Pharmabiz44m
NIH researchers develop biomarker score for predicting diets high in ultra-processed foods
NIH researchers develop biomarker score for predicting diets high in ultra-processed foods: Bethesda, Maryland Thursday, May 22, 2025, 17:00 Hrs [IST] For the first time, research ...
Pharmabiz1h
Malaysian MoH awards insulins supply contract extension to Biocon Biologics
Malaysian MoH awards insulins supply contract extension to Biocon Biologics: Our Bureau, Bengaluru Thursday, May 22, 2025, 16:15 Hrs [IST] Biocon Biologics has said that the Gover ...
Pharmabiz2h
EMA grants orphan drug designation to Quoin Pharma’s QRX003 for the treatment of Netherton syndrome
EMA grants orphan drug designation to Quoin Pharma’s QRX003 for the treatment of Netherton syndrome: Ashburn, Virginia Thursday, May 22, 2025, 15:00 Hrs [IST] Quoin Pharmaceutic ...
Pharmabiz1h
Venus Remedies secures Ukrainian GMP renewal, strengthening global pharmaceutical presence
Venus Remedies secures Ukrainian GMP renewal, strengthening global pharmaceutical presence: Our Bureau, Bengaluru Thursday, May 22, 2025, 16:30 Hrs [IST] Venus Remedies has succes ...
Pharmabiz3h
Lupus Research Alliance launches Lupus Nexus Foundational Analyses to accelerate personalized lupus treatments and a cure
Lupus Research Alliance launches Lupus Nexus Foundational Analyses to accelerate personalized lupus treatments and a cure: New York Thursday, May 22, 2025, 14:00 Hrs [IST] The Lup ...
Pharmabiz4h
Bayer initiates phase I study with GIRK4 inhibitor for treatment of patients with atrial fibrillation
Bayer initiates phase I study with GIRK4 inhibitor for treatment of patients with atrial fibrillation: Berlin Thursday, May 22, 2025, 13:00 Hrs [IST] Bayer announced initiation of ...
Pharmabiz6h
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer: Cambridge, UK Thursday, May ...
Pharmabiz5h
Roche provides update on US FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory DLBCL
Roche provides update on US FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory DLBCL: Basel Thursday, May 22, 2025, 12:00 Hrs [IST] Roche ...
Pharmabiz8h
Chugai Pharma announces positive results from phase III TALENTACE study of Tecentriq & Avastin for unresectable hepatocellular carcinoma
Chugai Pharma announces positive results from phase III TALENTACE study of Tecentriq & Avastin for unresectable hepatocellular carcinoma: Tokyo Thursday, May 22, 2025, 09:00 Hrs [ ...